Meta-analyses on Pediatric Infections and Vaccines

Infectious Disease Clinics of North America

Volumn 23, Issue 2, 2009, Pages 431-457

  Grammatikos, Alexandros P ^a,b   Mantadakis, Elpis ^c   Falagas, Matthew E ^a,d,e  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Acute gastroenteritis; Bronchiolitis; Children; Infections; Influenza vaccines; Meta analyses; Pneumococcal vaccines; Vaccines

Indexed keywords

ADRENALIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM; BRONCHODILATING AGENT; CEFPODOXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; CIPROFLOXACIN; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; PROCAINE PENICILLIN; RIBAVIRIN; SURFACTANT; UNINDEXED DRUG;

ACUTE GASTROENTERITIS; BACTERIAL MENINGITIS; BREATHING EXERCISE; BRONCHIOLITIS; CHILD; CLINICAL EFFECTIVENESS; COMMUNITY ACQUIRED PNEUMONIA; CROUP; CYSTIC FIBROSIS; DEHYDRATION; DIARRHEA; DISEASE EXACERBATION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG USE; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION; INFLUENZA; INJECTION SITE REACTION; LACTOBACILLUS; MENINGOCOCCOSIS; ORAL REHYDRATION THERAPY; PAPILLOMA; PNEUMONIA; REVIEW; SACCHAROMYCES; STREPTOCOCCUS PNEUMONIA; TONSILLITIS; TREATMENT FAILURE; URINARY TRACT INFECTION; VACCINATION; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; BRONCHIOLITIS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; GASTROENTERITIS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA, HUMAN; META-ANALYSIS AS TOPIC; PNEUMONIA, PNEUMOCOCCAL; VACCINATION; VACCINES; YOUNG ADULT;

EID: 65249159178     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.01.008     Document Type: Review

References (190)

1. Ten great public health achievements-United States, 1900-1999. MMWR Morb Mortal Wkly Rep 48 (1999) 241-243
2. Falagas M.E., Giannopoulou K.P., Vardakas K.Z., et al. Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis 8 (2008) 543-552
3. Bellemare S., Hartling L., Wiebe N., et al. Oral rehydration versus intravenous therapy for treating dehydration due to gastroenteritis in children: a meta-analysis of randomised controlled trials. BMC Med 2 (2004) 11
4. Fonseca B.K., Holdgate A., and Craig J.C. Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med 158 (2004) 483-490
5. Hartling L., Bellemare S., Wiebe N., et al. Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children. Cochrane Database Syst Rev 3 (2006) CD004390
6. Fontaine O., Gore S.M., and Pierce N.F. Rice-based oral rehydration solution for treating diarrhoea. Cochrane Database Syst Rev (2000) CD001264
7. Hahn S., Kim S., and Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev (2002) CD002847
8. King C.K., Glass R., Bresee J.S., et al. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 52 (2003) 1-16
9. Brown K.H., Peerson J.M., and Fontaine O. Use of nonhuman milks in the dietary management of young children with acute diarrhea: a meta-analysis of clinical trials. Pediatrics 93 (1994) 17-27
10. Lukacik M., Thomas R.L., and Aranda J.V. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. Pediatrics 121 (2008) 326-336
11. Patro B., Golicki D., and Szajewska H. Meta-analysis: zinc supplementation for acute gastroenteritis in children. Aliment Pharmacol Ther 28 (2008) 713-723
12. Aggarwal R., Sentz J., and Miller M.A. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 119 (2007) 1120-1130
13. Grotto I., Mimouni M., Gdalevich M., et al. Vitamin A supplementation and childhood morbidity from diarrhea and respiratory infections: a meta-analysis. J Pediatr 142 (2003) 297-304
14. Sazawal S., Hiremath G., Dhingra U., et al. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6 (2006) 374-382
15. Johnston B.C., Supina A.L., Ospina M., et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev (2007) CD004827
16. Allen S.J., Okoko B., Martinez E., et al. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev (2004) CD003048
17. Huang J.S., Bousvaros A., Lee J.W., et al. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47 (2002) 2625-2634
18. Johnston B.C., Supina A.L., and Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 175 (2006) 377-383
19. Van Niel C.W., Feudtner C., Garrison M.M., et al. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109 (2002) 678-684
20. Szajewska H., Skorka A., and Dylag M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25 (2007) 257-264
21. Szajewska H., Skorka A., Ruszczynski M., et al. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 25 (2007) 871-881
22. Szajewska H., Ruszczynski M., and Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 149 (2006) 367-372
23. Alhashimi D., Alhashimi H., and Fedorowicz Z. Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev (2006) CD005506
24. Szajewska H., Gieruszczak-Bialek D., and Dylag M. Meta-analysis: ondansetron for vomiting in acute gastroenteritis in children. Aliment Pharmacol Ther 25 (2007) 393-400
25. Szajewska H., Dziechciarz P., and Mrukowicz J. Meta-analysis: smectite in the treatment of acute infectious diarrhoea in children. Aliment Pharmacol Ther 23 (2006) 217-227
26. DeCamp L.R., Byerley J.S., Doshi N., et al. Use of antiemetic agents in acute gastroenteritis: a systematic review and meta-analysis. Arch Pediatr Adolesc Med 162 (2008) 858-865
27. Jacobs J., Jonas W.B., Jimenez-Perez M., et al. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatr Infect Dis J 22 (2003) 229-234
28. Soares-Weiser K., Goldberg E., Tamimi G., et al. Rotavirus vaccine for preventing diarrhoea. Cochrane Database Syst Rev (2004) CD002848
29. Gadomski A.M., and Bhasale A.L. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 3 (2006) CD001266
30. Kellner J.D., Ohlsson A., Gadomski A.M., et al. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 150 (1996) 1166-1172
31. Hartling L., Wiebe N., Russell K., et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev (2004) CD003123
32. Smucny J., Becker L., and Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev (2006) CD001726
33. Flores G., and Horwitz R.I. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 100 (1997) 233-239
34. Spurling G.K., Fonseka K., Doust J., et al. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev (2007) CD005189
35. Ventre K., Haroon M., and Davison C. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev 3 (2006) CD005150
36. Ventre K., and Randolph A.G. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev (2007) CD000181
37. Garrison M.M., Christakis D.A., Harvey E., et al. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics 105 (2000) E44
38. Blom D., Ermers M., Bont L., et al. Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing. Cochrane Database Syst Rev (2007) CD004881
39. Patel H., Platt R., Lozano J.M., et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev (2004) CD004878
40. Davison C., Ventre K.M., Luchetti M., et al. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 5 (2004) 482-489
41. Perrotta C., Ortiz Z., and Roque M. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev (2007) CD004873
42. Dherani M., Pope D., Mascarenhas M., et al. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ 86 (2008) 390-8C
43. Flood R.G., Badik J., and Aronoff S.C. The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children. Pediatr Infect Dis J 27 (2008) 95-99
44. Sazawal S., and Black R.E. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 3 (2003) 547-556
45. Kabra S.K., Lodha R., and Pandey R.M. Antibiotics for community acquired pneumonia in children. Cochrane Database Syst Rev 3 (2006) CD004874
46. Haider B.A., Saeed M.A., and Bhutta Z.A. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev (2008) CD005976
47. Rojas M.X., and Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Cochrane Database Syst Rev (2006) CD004979
48. Gavranich J.B., and Chang A.B. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to mycoplasma pneumoniae in children. Cochrane Database Syst Rev (2005) CD004875
49. Chen H., Zhuo Q., Yuan W., et al. Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age. Cochrane Database Syst Rev (2008) CD006090
50. Ni J., Wei J., and Wu T. Vitamin a for non-measles pneumonia in children. Cochrane Database Syst Rev (2005) CD003700
51. Smith S.M., Schroeder K., and Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev (2008) CD001831
52. Marchant J.M., Morris P., Gaffney J.T., et al. Antibiotics for prolonged moist cough in children. Cochrane Database Syst Rev (2005) CD004822
53. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 113 (2004) 1451-1465
54. Segal N., Leibovitz E., Dagan R., et al. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 69 (2005) 1311-1319
55. Koopman L., Hoes A.W., Glasziou P.P., et al. Antibiotic therapy to prevent the development of asymptomatic middle ear effusion in children with acute otitis media: a meta-analysis of individual patient data. Arch Otolaryngol Head Neck Surg 134 (2008) 128-132
56. Rovers M.M., Glasziou P., Appelman C.L., et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 368 (2006) 1429-1435
57. Glasziou P.P., Del Mar C.B., Sanders S.L., et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev (2004) CD000219
58. Damoiseaux R.A., van Balen F.A., Hoes A.W., et al. Antibiotic treatment of acute otitis media in children under two years of age: evidence based?. Br J Gen Pract 48 (1998) 1861-1864
59. Rosenfeld R.M., Vertrees J.E., Carr J., et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr 124 (1994) 355-367
60. Del Mar C., Glasziou P., and Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 314 (1997) 1526-1529
61. Kozyrskyj A.L., Hildes-Ripstein G.E., Longstaffe S.E., et al. Short course antibiotics for acute otitis media. Cochrane Database Syst Rev (2000) CD001095
62. Kozyrskyj A.L., Hildes-Ripstein G.E., Longstaffe S.E., et al. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA 279 (1998) 1736-1742
63. Leach A.J., and Morris P.S. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev (2006) CD004401
64. Coleman C., and Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev (2008) CD001727
65. Foxlee R., Johansson A., Wejfalk J., et al. Topical analgesia for acute otitis media. Cochrane Database Syst Rev 3 (2006) CD005657
66. Corbeel L. What is new in otitis media?. Eur J Pediatr 166 (2007) 511-519
67. Roberts J.E., Rosenfeld R.M., and Zeisel S.A. Otitis media and speech and language: a meta-analysis of prospective studies. Pediatrics 113 (2004) e238-48
68. Simpson S.A., Thomas C.L., van der Linden M.K., et al. Identification of children in the first four years of life for early treatment for otitis media with effusion. Cochrane Database Syst Rev (2007) CD004163
69. Griffin G.H., Flynn C., Bailey R.E., et al. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev (2006) CD003423
70. Thomas C.L., Simpson S., Butler C.C., et al. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev 3 (2006) CD001935
71. Berman S., Roark R., and Luckey D. Theoretical cost effectiveness of management options for children with persisting middle ear effusions. Pediatrics 93 (1994) 353-363
72. Rovers M.M., Black N., Browning G.G., et al. Grommets in otitis media with effusion: an individual patient data meta-analysis. Arch Dis Child 90 (2005) 480-485
73. Lous J., Burton M.J., Felding J.U., et al. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev (2005) CD001801
74. Perera R., Haynes J., Glasziou P., et al. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database Syst Rev (2006) CD006285
75. Russell K., Wiebe N., Saenz A., et al. Glucocorticoids for croup. Cochrane Database Syst Rev (2004) CD001955
76. Ausejo M., Saenz A., Pham B., et al. The effectiveness of glucocorticoids in treating croup: meta-analysis. BMJ 319 (1999) 595-600
77. Kairys S.W., Olmstead E.M., and O'Connor G.T. Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics 83 (1989) 683-693
78. Moore M., and Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev 3 (2006) CD002870
79. Brook I. A pooled comparison of cefdinir and penicillin in the treatment of group A beta-hemolytic streptococcal pharyngotonsillitis. Clin Ther 27 (2005) 1266-1273
80. Deeter R.G., Kalman D.L., Rogan M.P., et al. Therapy for pharyngitis and tonsillitis caused by group a beta-hemolytic streptococci: a meta-analysis comparing the efficacy and safety of cefadroxil monohydrate versus oral penicillin V. Clin Ther 14 (1992) 740-754
81. Pichichero M.E., and Margolis P.A. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 10 (1991) 275-281
82. Casey J.R., and Pichichero M.E. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 113 (2004) 866-882
83. Lan A.J., Colford J.M., and Colford Jr. J.M. The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: a meta-analysis. Pediatrics 105 (2000) E19
84. Falagas M.E., Vouloumanou E.K., Matthaiou D.K., et al. Effectiveness and safety of short-course vs long-course antibiotic therapy for group A beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc 83 (2008) 880-889
85. Wu Y.P., and Roberts M.C. A meta-analysis of interventions to increase adherence to medication regimens for pediatric otitis media and streptococcal pharyngitis. J Pediatr Psychol 33 (2008) 789-796
86. Dhiwakar M., Clement W.A., Supriya M., et al. Antibiotics to reduce post-tonsillectomy morbidity. Cochrane Database Syst Rev (2008) CD005607
87. Del Mar C.B., Glasziou P.P., and Spinks A.B. Antibiotics for sore throat. Cochrane Database Syst Rev (2004) CD000023
88. Shaikh N., Morone N.E., Bost J.E., et al. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 27 (2008) 302-308
89. Gorelick M.H., and Shaw K.N. Screening tests for urinary tract infection in children: a meta-analysis. Pediatrics 104 (1999) e54
90. Huicho L., Campos-Sanchez M., and Alamo C. Metaanalysis of urine screening tests for determining the risk of urinary tract infection in children. Pediatr Infect Dis J 21 (2002) 1-11 88
91. Hodson E.M., Willis N.S., and Craig J.C. Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2007) CD003772
92. Keren R., and Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics 109 (2002) E70
93. Michael M., Hodson E.M., Craig J.C., et al. Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children. Cochrane Database Syst Rev (2003) CD003966
94. Tran D., Muchant D.G., and Aronoff S.C. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients. J Pediatr 139 (2001) 93-99
95. Williams G.J., Wei L., Lee A., et al. Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 3 (2006) CD001534
96. Sudarsanam T., Rupali P., Tharyan P., et al. Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev (2008) CD005437
97. Prasad K., Kumar A., Gupta P.K., et al. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis. Cochrane Database Syst Rev (2007) CD001832
98. Shah S., Ohlsson A., and Shah V. Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev (2004) CD004496
99. Fraser A., Gafter-Gvili A., Paul M., et al. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev (2006) CD004785
100. Baraff L.J., Oslund S., and Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics 92 (1993) 140-143
101. Rothrock S.G., Harper M.B., Green S.M., et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics 99 (1997) 438-444
102. Bulloch B., Craig W.R., and Klassen T.P. The use of antibiotics to prevent serious sequelae in children at risk for occult bacteremia: a meta-analysis. Acad Emerg Med 4 (1997) 679-683
103. Rothrock S.G., Green S.M., Harper M.B., et al. Parenteral vs oral antibiotics in the prevention of serious bacterial infections in children with streptococcus pneumoniae occult bacteremia: a meta-analysis. Acad Emerg Med 5 (1998) 599-606
104. van de Beek D., de Gans J., McIntyre P., et al. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev (2007) CD004405
105. McIntyre P.B., Berkey C.S., King S.M., et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278 (1997) 925-931
106. Yurkowski P.J., and Plaisance K.I. Prevention of auditory sequelae in pediatric bacterial meningitis: a meta-analysis. Pharmacotherapy 13 (1993) 494-499
107. Geiman B.J., and Smith A.L. Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials. West J Med 157 (1992) 27-31
108. Havens P.L., Wendelberger K.J., Hoffman G.M., et al. Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. Am J Dis Child 143 (1989) 1051-1055
109. Maconochie I., Baumer H., and Stewart M.E. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev (2008) CD004786
110. Waters V., and Ratjen F. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of pseudomonas aeruginosa in cystic fibrosis. Cochrane Database Syst Rev (2008) CD006961
111. Southern K.W., Barker P.M., and Solis A. Macrolide antibiotics for cystic fibrosis. Cochrane Database Syst Rev (2004) CD002203
112. Elphick H.E., and Tan A. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Cochrane Database Syst Rev (2005) CD002007
113. Smyth A.R., and Tan K.H. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev 3 (2006) CD002009
114. Balaguer A., and Gonzalez de Dios J. Home intravenous antibiotics for cystic fibrosis. Cochrane Database Syst Rev (2008) CD001917
115. Remmington T., Jahnke N., and Harkensee C. Oral anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev (2007) CD005405
116. Fernandes B., Plummer A., and Wildman M. Duration of intravenous antibiotic therapy in people with cystic fibrosis. Cochrane Database Syst Rev (2008) CD006682
117. Ryan G., Mukhopadhyay S., and Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev (2003) CD001021
118. Breen L., and Aswani N. Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev (2001) CD002767
119. Wood D.M., and Smyth A.R. Antibiotic strategies for eradicating pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev (2006) CD004197
120. Smyth A., and Walters S. Prophylactic antibiotics for cystic fibrosis. Cochrane Database Syst Rev (2003) CD001912
121. Keogan M.T., and Johansen H.K. Vaccines for preventing infection with pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev (2000) CD001399
122. Tan A., Bhalla P., and Smyth R. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev (2000) CD001753
123. Beyer W.E., Palache A.M., de Jong J.C., et al. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20 (2002) 1340-1353
124. Beyer W.E., Palache A.M., and Osterhaus A.D. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines: a review and meta-analysis of the literature. Clin Drug Investig 15 (1998) 1-12
125. Beyer W.E., Palache A.M., Kerstens R., et al. Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies. Eur J Clin Microbiol Infect Dis 15 (1996) 65-70
126. Jefferson T., Rivetti A., Harnden A., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev (2008) CD004879
127. Manzoli L., Schioppa F., Boccia A., et al. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 26 (2007) 97-106
128. Negri E., Colombo C., Giordano L., et al. Influenza vaccine in healthy children: a meta-analysis. Vaccine 23 (2005) 2851-2861
129. Jefferson T.O., Rivetti D., Di Pietrantonj C., et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (2007) CD001269
130. Villari P., Manzoli L., and Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 22 (2004) 3475-3486
131. Poole P.J., Chacko E., Wood-Baker R.W., et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) CD002733
132. Atashili J., Kalilani L., and Adimora A.A. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 6 (2006) 138
133. Keller T., Weeda V.B., van Dongen C.J., et al. Influenza vaccines for preventing coronary heart disease. Cochrane Database Syst Rev (2008) CD005050
134. Cates C.J., Jefferson T.O., and Rowe B.H. Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev (2008) CD000364
135. Chang C.C., Morris P.S., and Chang A.B. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst Rev (2007) CD006218
136. Anema A., Mills E., Montaner J., et al. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 9 (2008) 57-61
137. Rivetti D., Jefferson T., Thomas R., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3 (2006) CD004876
138. Vu T., Farish S., Jenkins M., et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831-1836
139. Gross P.A., Hermogenes A.W., Sacks H.S., et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
140. Puig Barbera J., and Marquez Calderon S. Effectiveness of influenza vaccine in the elderly. A critical review of the bibliography. Med Clin (Barc) 105 (1995) 645-648
141. Thomas R.E., Jefferson T., Demicheli V., et al. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 3 (2006) CD005187
142. Lucero M.G., Dulalia V.E., Parreno R.N., et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. Cochrane Database Syst Rev (2004) CD004977
143. Straetemans M., Sanders E.A., Veenhoven R.H., et al. Pneumococcal vaccines for preventing otitis media. Cochrane Database Syst Rev (2004) CD001480
144. Chaithongwongwatthana S., Yamasmit W., Limpongsanurak S., et al. Pneumococcal vaccination during pregnancy for preventing infant infection. Cochrane Database Syst Rev (2006) CD004903
145. Moberley S.A., Holden J., Tatham D.P., et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev (2008) CD000422
146. Cornu C., Yzebe D., Leophonte P., et al. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 19 (2001) 4780-4790
147. Moore R.A., Wiffen P.J., and Lipsky B.A. Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials. BMC Fam Pract 1 (2000) 1
148. Fine M.J., Smith M.A., Carson C.A., et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 154 (1994) 2666-2677
149. Hutchison B.G., Oxman A.D., Shannon H.S., et al. Clinical effectiveness of pneumococcal vaccine. Meta-analysis. Can Fam Physician 45 (1999) 2381-2393
150. Melegaro A., and Edmunds W.J. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 19 (2004) 353-363
151. Granger R., Walters J., Poole P.J., et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) CD001390
152. Sheikh A., Alves B., and Dhami S. Pneumococcal vaccine for asthma. Cochrane Database Syst Rev (2002) CD002165
153. Davies E.G., Riddington C., Lottenberg R., et al. Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev (2004) CD003885
154. Patel M., and Lee C.K. Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. Cochrane Database Syst Rev (2005) CD001093
155. Conterno L.O., Silva Filho C.R., Ruggeberg J.U., et al. Conjugate vaccines for preventing meningococcal C meningitis and septicaemia. Cochrane Database Syst Rev 3 (2006) CD001834
156. Pollabauer E.M., Petermann R., and Ehrlich H.J. Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology. Hum Vaccin 1 (2005) 131-139
157. Swingler G., Fransman D., and Hussey G. Conjugate vaccines for preventing Haemophilus influenzae type b infections. Cochrane Database Syst Rev (2007) CD001729
158. Obonyo C.O., and Lau J. Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. Eur J Clin Microbiol Infect Dis 25 (2006) 90-97
159. Foxwell A.R., Cripps A.W., and Dear K.B. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database Syst Rev (2006) CD001958
160. Mathew J.L., El Dib R., Mathew P.J., et al. Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database Syst Rev (2008) CD006481
161. Lee C., Gong Y., Brok J., et al. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst Rev (2006) CD004790
162. Chen W., and Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev (2005) CD000100
163. Fabrizi F., Martin P., Dixit V., et al. Meta-analysis: the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther 20 (2004) 1053-1062
164. Fisman D.N., Agrawal D., and Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 35 (2002) 1368-1375
165. Schroth R.J., Hitchon C.A., Uhanova J., et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev (2004) CD003775
166. Fabrizi F., Dixit V., Magnini M., et al. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther 24 (2006) 497-506
167. Cruciani M., Mengoli C., Serpelloni G., et al. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis. Vaccine 25 (2007) 709-718
168. Fabrizi F., Dixit V., and Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 23 (2006) 1559-1566
169. Fabrizi F., Ganeshan S.V., Dixit V., et al. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 24 (2006) 789-796
170. Fabrizi F., Dixit V., Bunnapradist S., et al. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population. Aliment Pharmacol Ther 23 (2006) 1105-1112
171. Wang L., Turner M.O., Elwood R.K., et al. A meta-analysis of the effect of bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57 (2002) 804-809
172. Rodrigues L.C., Diwan V.K., and Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22 (1993) 1154-1158
173. Colditz G.A., Berkey C.S., Mosteller F., et al. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96 (1995) 29-35
174. Trunz B.B., Fine P., and Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367 (2006) 1173-1180
175. Setia M.S., Steinmaus C., Ho C.S., et al. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6 (2006) 162-170
176. Zodpey SP. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian J Dermatol Venereol Leprol 73 (2007) 86-93
177. Han R.F., and Pan J.G. Can intravesical bacillus Calmette-Guerin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology 67 (2006) 1216-1223
178. Sylvester R.J., van der Meijden A.P., Witjes J.A., et al. Bacillus Calmette-Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174 (2005) 86-91 [discussion, 91-2]
179. Shelley M.D., Wilt T.J., Court J., et al. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int 93 (2004) 485-490
180. Sylvester R.J., van der M.A., and Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168 (2002) 1964-1970
181. Bohle A., and Bock P.R. Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63 (2004) 682-686 [discussion, 86-7]
182. Huncharek M., and Kupelnick B. The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder: a metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy. Am J Clin Oncol 27 (2004) 522-528
183. La Torre G., de Waure C., Chiaradia G., et al. HPV vaccine efficacy in
184. Bhatla N., Lal N., Bao Y.P., et al. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 26 (2008) 2811-2817
185. Bao Y.P., Li N., Wang H., et al. [Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis]. Zhonghua Liu Xing Bing Xue Za Zhi 28 (2007) 941-946
186. Bae J.H., Lee S.J., Kim C.J., et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 18 (2008) 788-794
187. Bao Y.P., Li N., Smith J.S., et al. Human papillomavirus type-distribution in the cervix of chinese women: a meta-analysis. Int J STD AIDS 19 (2008) 106-111
188. Smith J.S., Lindsay L., Hoots B., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 (2007) 621-632
189. Clifford G.M., Smith J.S., Aguado T., et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89 (2003) 101-105
190. Brotherton J.M. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine 26 (2008) 250-256